Contracture
发表于 2025-3-26 21:48:26
http://reply.papertrans.cn/17/1650/164937/164937_31.png
狗窝
发表于 2025-3-27 01:18:48
Tom P. Evans,Glen M. Green,Laura A. Carlsonfetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.
obeisance
发表于 2025-3-27 05:35:48
http://reply.papertrans.cn/17/1650/164937/164937_33.png
变形词
发表于 2025-3-27 12:01:28
https://doi.org/10.1007/978-94-009-0005-9CIS deserves a careful discussion of the various treatment options, including accurate recurrence risk estimates and the relative importance to her of the risks and benefits of each option, to help her choose the optimal treatment for her.
同步信息
发表于 2025-3-27 17:14:38
,Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor?, as a precursor lesion for invasive cancer in some cases. The primary purpose of this chapter is to detail the evidence in support of the current view, LCIS as . a risk factor, conferring increased risk of both ipsilateral and contralateral invasive carcinoma, and a non-obligate precursor lesion at or near the site of the index lesion.
傀儡
发表于 2025-3-27 20:42:29
,Ductal Carcinoma In Situ: Risk Factor or Cancer,arly cancer. While there is survival benefit with surgery and radiotherapy, treatment needs to be personalized, and better predictors of outcome need to be developed and tested in clinical trials to better implement therapeutic decision-making.
弯曲的人
发表于 2025-3-28 00:23:18
http://reply.papertrans.cn/17/1650/164937/164937_37.png
Foregery
发表于 2025-3-28 03:59:14
http://reply.papertrans.cn/17/1650/164937/164937_38.png
conquer
发表于 2025-3-28 06:52:43
Prophylactic Mastectomy in Patients with Atypical Breast Lesions,fetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.
Jacket
发表于 2025-3-28 11:25:08
The Nonsurgical Management of Ductal Carcinoma In Situ (DCIS),ed with surgical intervention. Alternative strategies harnessing immune responses, including vaccination, are underway. Quality of life and patient reported outcomes will also guide whether nonsurgical interventions may, in future, become standard of care for selected women with DCIS.